{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:31:02Z","timestamp":1782509462886,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003286","name":"Kuwait Foundation for the Advancement of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omtm.2020.06.017","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T21:12:45Z","timestamp":1593033165000},"page":"321-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19"],"prefix":"10.1016","volume":"18","author":[{"given":"Mira","family":"Bosso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thangavel Alphonse","family":"Thanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abu-Farha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muath","family":"Alanbaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Abubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahd","family":"Al-Mulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.06.017_bib1","doi-asserted-by":"crossref","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"55","author":"Guan","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtm.2020.06.017_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med"},{"key":"10.1016\/j.omtm.2020.06.017_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.06.017_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.omtm.2020.06.017_bib5","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.06.017_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1871528113666140713164506","article-title":"ACE and ACE2 in inflammation: a tale of two enzymes","volume":"13","author":"Gaddam","year":"2014","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.omtm.2020.06.017_bib7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/01.HYP.0000244543.91937.79","article-title":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study","volume":"48","author":"Rice","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.omtm.2020.06.017_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","volume":"53","author":"Devaux","year":"2020","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.omtm.2020.06.017_bib9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/1470320311405557","article-title":"A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project","volume":"12","author":"Vangjeli","year":"2011","journal-title":"J.\u00a0Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.omtm.2020.06.017_bib10","doi-asserted-by":"crossref","first-page":"e12917","DOI":"10.1097\/MD.0000000000012917","article-title":"Association of angiotensin-converting enzyme 2 gene polymorphism and enzymatic activity with essential hypertension in different gender: A case-control study","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.omtm.2020.06.017_bib11","first-page":"91","article-title":"Association of angiotensin-converting enzyme 2 gene A\/G polymorphism and elevated blood pressure in Chinese patients with metabolic syndrome","volume":"147","author":"Zhong","year":"2006","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.omtm.2020.06.017_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.trsl.2007.06.002","article-title":"Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese","volume":"150","author":"Niu","year":"2007","journal-title":"Transl. Res."},{"key":"10.1016\/j.omtm.2020.06.017_bib13","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1007\/s11033-012-1487-1","article-title":"ACE2 gene polymorphism and essential hypertension: an updated meta-analysis involving 11,051 subjects","volume":"39","author":"Lu","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omtm.2020.06.017_bib14","doi-asserted-by":"crossref","first-page":"e3876","DOI":"10.1097\/MD.0000000000003876","article-title":"Association between circulating levels of ACE2-Ang-(1-7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.omtm.2020.06.017_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03014460.2013.837195","article-title":"Association of angiotensin-converting enzyme and angiotensin-converting enzyme-2 gene polymorphisms with essential hypertension in the population of Odisha, India","volume":"41","author":"Patnaik","year":"2014","journal-title":"Ann. Hum. Biol."},{"key":"10.1016\/j.omtm.2020.06.017_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00029330-200801010-00006","article-title":"Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy","volume":"121","author":"Wang","year":"2008","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.omtm.2020.06.017_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12944-018-0890-6","article-title":"Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China","volume":"17","author":"Pan","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.omtm.2020.06.017_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41440-018-0166-6","article-title":"Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang","volume":"42","author":"Luo","year":"2019","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.omtm.2020.06.017_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00109-005-0718-5","article-title":"Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy","volume":"84","author":"Lieb","year":"2006","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.omtm.2020.06.017_bib20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1-7)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.omtm.2020.06.017_bib21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/j.1476-5381.2012.01905.x","article-title":"Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1\/2- and NF-\u03baB-dependent pathways","volume":"166","author":"El-Hashim","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.omtm.2020.06.017_bib22","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.06.017_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.HYP.0000063886.71596.C8","article-title":"Hypothesis: ACE2 modulates blood pressure in the mammalian organism","volume":"41","author":"Yagil","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.omtm.2020.06.017_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccc.2018.11.002","article-title":"Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill","volume":"35","author":"Bitker","year":"2019","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.omtm.2020.06.017_bib25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.06.017_bib26","article-title":"Treatment with ACE-inhibitors is not associated with early severe SARS-Covid-19 infection in a multi-site UK acute Hospital Trust","author":"Bean","year":"2020","journal-title":"ResearchGate"},{"key":"10.1016\/j.omtm.2020.06.017_bib27","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/JVI.01248-09","article-title":"Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63","volume":"84","author":"Glowacka","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.06.017_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41581-020-0279-4","article-title":"Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic","volume":"16","author":"South","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.omtm.2020.06.017_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvaa093","article-title":"The role of angiotensin-converting enzyme 2 in coronaviruses\/influenza viruses and cardiovascular disease","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtm.2020.06.017_bib30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.omtm.2020.06.017_bib31","first-page":"341","article-title":"Pharmacogenomics and hypertension: Current insights","volume":"12","author":"Oliveira-Paula","year":"2019","journal-title":"Pharm. Genomics Pers. Med."},{"key":"10.1016\/j.omtm.2020.06.017_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jcpt.12625","article-title":"Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites","volume":"43","author":"Chen","year":"2018","journal-title":"J.\u00a0Clin. Pharm. Ther."},{"key":"10.1016\/j.omtm.2020.06.017_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.clpt.6100214","article-title":"Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women","volume":"82","author":"Fan","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtm.2020.06.017_bib35","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.18632\/aging.103415","article-title":"ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy","volume":"12","author":"Asselta","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.omtm.2020.06.017_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.omtm.2020.06.017_bib37","article-title":"A comprehensive germline variant and expression analyses of ACE2, TMPRSS2 and SARS-CoV-2 activator FURIN genes from the Middle East: Combating SARS-CoV-2 with precision medicine","author":"Al-mulla","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2020.06.017_bib38","article-title":"Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility","author":"Stawiski","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2020.06.017_bib39","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.06.017_bib40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjhyper.2004.02.022","article-title":"No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension","volume":"17","author":"Benjafield","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.omtm.2020.06.017_bib41","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ahj.2008.06.013","article-title":"Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort","volume":"156","author":"Palmer","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.omtm.2020.06.017_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00029330-200801010-00006","article-title":"Polymorphisms of angiotensin-converting enzyme 2 gene associated with magnitude of left ventricular hypertrophy in male patients with hypertrophic cardiomyopathy","volume":"121","author":"Wang","year":"2008","journal-title":"Chin. Med. J. (Engl)."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120301418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:46Z","timestamp":1762421146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120301418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"alternative-id":["S2329050120301418"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.06.017","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Dasman Diabetes Institute.","name":"copyright","label":"Copyright"}]}}